Rapporto annuale 2004 - Istituto di Ricerche Farmacologiche Mario ...

Cancer Inst, 96: 750-758 (2004).
IRFMN
Selvaggi G, Novello S, Torri V, Leonardo E, De Giuli P, Borasio P, Mossetti C, Ardissone F, Lausi P, Scagliotti G V.
Epidermal growth factor receptor everexpression correlates with a poor prognosis in completely resected non-smallcell
lung cancer. Ann Oncol, 15: 28-32 (2004).
Johnson F E, Virgo K S, Fossati R. Follow-up for patients with colorectal cancer after curative-intent primary
treatment. J Clin Oncol, 22: 1363-1365 (2004).
Paccagnella A, Favaretto A, Oniga F, Barbieri F, Ceresoli G, Torri V, Villa E, Verusio C, Cetto G L, Santo A, De
Pangher V, Artioli F, Cacciani G C, Parodi G, Soresi F, Ghi M G, Morabito A, Biason R, Giusto M, Mosconi P,
Chiarion Sileni V, Gruppo di Studio Tumori Polmonari del Veneto. Cisplatin versus carboplatin in combination with
mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial. Lung
Cancer, 43: 83-91 (2004).
Scagliotti GV, Torri V. Should we be using adjuvant chemotherapy for non-small cell lung cancer? Not yet In: 2004
ASCO Annual meeting. American Society Clinical Oncology, New Orleans, 501-510 (2004).
Perrone F, Marangolo M, Di Costanzo F, Colucci G, Repetto L, Merlano M, De Placido S, Torri V, Comella G,
Labianca R, Parisi V, Gallo C. Insurance for independent cancer trials. Ann Oncol, 15: 1722-1723 (2004).
Gregorc V, Ceresoli G, Floriani I, Spreafico A, Bencardino K B, Ludovini V, Pistola L, Mihaylova Z, Tofanetti F R,
Ferraldeschi M, Torri V, Cappuzzo F, Aarden L A, Tonato M, Villa E. Effects of Gefitinib on serum epidermal
growth factor receptor and HER2 in patients with advanced non-small cell lung cancer. Clin Cancer Res, 10: 6006-
6012 (2004).
Alonso J., Ferrer M., Gandek B., Ware J.E., Aaronson N.K., Mosconi P., Rasmussen N.K., Bullinger M., Fukuhara
S., Kaasa S., Leplege A., and the IQOLA Project Group. Functional health and well-being of the chronically ill in
eight countries: results from the International Qualità of Life Assessment (IQOLA) project. Quality of Life Research,
13: 283-298 (2004).
Marchesini G., Melchionda N., Apolone G., Cuzzolaro M., Mannucci E., Grossi E. and the QUOVADIS Study
Group. Prevalence of the metabolic syndrome in treatment-seeking obese persons. Metabolism, 53 (4): 435-440
(2004)..
Gallus S., Pacifici R., Colombo P., Scarpino V., Zuccaro P., Bosetti C., Apolone G., La Vecchia C., Smoking in Italy
2003, with a focus on the young. Tumori 90: 171-174 (2004).
Apolone G, Garattini S., Drugs policy and market in europe: a useful example for the USA? J.Amb.Care
Management 27:88 (2004).
Pironi L., Paganelli F., Mosconi P., Morselli-Labate A.M., Spinucci G., Merli C., Guidetti M., Miglioli M., The SF-
36 instrument for the follow-up of healt-related quality-of-life assessment of patients undergoing home parenteral
nutrition for benign disease, Transplantation Proceedings 36: 254-258 (2004).
Zwahlen M., D’Avanzo B., Egger M., Berrino F., Perneger T., Mosconi P., Domenighetti G. Women’s perception of
the benefits of mammography screening: population-based survey in four countries: authors reply. Int.J.Epidemiol.,
33: 1-2 (2004).
SELEZIONE PUBBLICAZIONI DIVULGATIVE APPARSE
NELL'ANNO 2004
Giavazzi R., Aglietta M., Astolfi A., Falanga A., Fusco A., Labianca R., Lollini P.L., Lombardo C., Natali P.G.,
Pierotti M.A., Presta M., Santoro M., Taraboletti G., Zupi G., Vecchio G. Meeting report. 45th Annual Meeting of the
Italian Cancer Society. Tumori, 90:356-362 (2004).
19
RAPPORTO ATTIVITA’ 2004